 CVRx(R) Enrolls First Patient In HOPE4HF™ Clinical Trial
 04.10.2009 3:00  16 views  0 comments
 CVRx, Inc. reported the first enrollment of a patient in the HOPE4HF Trial, a study that is evaluating the Rheos System to treat heart failure. The Rheos System uses Baroreflex Activation Therapy® technology, an entirely new non-pharmaceutical approach designed to treat cardiovascular disease. The HOPE4HF Trial is being conducted under an approved investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA). Read more »
|
New Sources Of Omega-3 From Grains And Lamb
03.10.2009 3:00 20 views 0 comments
 CSIRO Food Futures Flagship scientist, Dr Surinder Singh, will outline his team's progress on the transfer into crop plants of biochemical pathways for long-chain omega-3 synthesis sourced from marine microalgae. "Long-chain omega-3 oils such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have well-documented health benefits against coronary heart disease, rheumatoid arthritis and other disorders," Dr Singh says. Read more »
|
Research Highlights Of The October 2009 Issue Of Ophthalmology
03.10.2009 3:00 13 views 0 comments
 Highlights of October's Ophthalmology, the journal of the American Academy of Ophthalmology, include good news on preserving vision in people with type 1 diabetes, a warning from the Cardiovascular Health Study for macular degeneration patients, and a report on how vision impacts well-being across the lifespan. Read more »
|
MiCardia(R) Announces Issuance Of Ninth US Patent In Structural Heart Disease -- "Shape Memory Devices And Methods For Reshaping Heart Anatomy"
02.10.2009 17:00 17 views 0 comments
 MiCardia® (MiCardia® Corporation, Irvine, California) announced that The United States Patent Office granted patent number US7,594,887 B2, "Shape Memory Devices and Methods for Reshaping Heart Anatomy," on September 29th, 2009. MiCardia Chief Technical Officer, Founder and co-inventor, Mr. Samuel Shaolian describes the patent as allowing for systems, methods and devices capable of reshaping the anatomy of the heart by implanting shape memory elements. Read more »
|
Heart Attack And Stroke Prevented In Large, Diverse Population By Bundling 2 Low-Cost Heart Drugs
02.10.2009 8:00 20 views 0 comments
 A program that bundled two generic, low-cost drugs - a cholesterol-lowering statin and a blood pressure-lowering drug - and gave daily doses to 68,560 people with diabetes or heart disease for two years is estimated to have prevented 1,271 heart attacks and strokes in the first year following the study period, according to a Kaiser Permanente study published online in the American Journal of Managed Care. Read more »
|
The Need To Know - PAC Examines Heart Patients And Their Medications, Australia
02.10.2009 6:00 16 views 0 comments
 The aftermath of a heart attack or the recovery from bypass surgery or percutaneous intervention can be confronting for many patients. The reality is that many of these patients may have never taken medicines before and most will require at least four medications to reduce their risk of further adverse cardiovascular events, many of them for life. Read more »
|
British Heart Foundation Recommends Eating Oily Fish For Heart Health
02.10.2009 4:00 19 views 0 comments
 In response to a study in the European Journal of Heart Failure on fish oils and the incidence of heart failure, British Heart Foundation (BHF) Senior Cardiac Nurse June Davison said: "This study found that eating oily fish did not offer protection against heart failure - although for people with diabetes a possible protective effect was found. However we need further research to confirm this. Read more »
|
Positive Trend Found For Diabetic Eye Health; Macular Degeneration Linked To Heart Disease; How Poor Vision Impacts Social, Economic Success
02.10.2009 4:00 17 views 0 comments
 Highlights of October's Ophthalmology, the journal of the American Academy of Ophthalmology, include good news on preserving vision in people with type 1 diabetes, a warning from the Cardiovascular Health Study for macular degeneration patients, and look at vision's impact on well-being across the lifespan. Read more »
|
Corthera's Relaxin Receives FDA Fast Track Designation For The Treatment Of Acute Heart Failure
02.10.2009 4:00 31 views 0 comments
Corthera Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to relaxin, the company's investigational drug for the treatment of acute heart failure (AHF). The Fast Track program facilitates the development and expedites the review of new drugs intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. Read more »
|
Cardiac Stem Cell Trial Seeks To Treat Some Heart Attack Patients
01.10.2009 10:00 16 views 0 comments
 Researchers at UCSF Medical Center have begun enrollment for an early-stage clinical trial to evaluate the safety and efficacy of an adult stem cell therapy for patients who have just experienced their first acute myocardial infarction, or heart attack. The trial is part of a multi-center national study. The cells used, known as mesenchymal stem cells, were obtained from the bone marrow of healthy adult donors. Read more »
|
Risk Of Heart Disease Increased By Prenatal Exposure To Flu Pandemic
01.10.2009 7:00 17 views 0 comments
 People exposed to a H1NI strain of influenza A while in utero were significantly more likely to have cardiovascular disease later in life, reveals a new study published in Journal of Developmental Origins of Health and Disease on Oct. 1. "Our point is that during pregnancy, even mild sickness from flu could affect development with longer consequences," said senior author Caleb Finch, USC professor of gerontology and biological sciences. Read more »
|
Screening Over Thirty Years For Healthy Hearts
01.10.2009 5:00 20 views 0 comments
 Researchers at the University of Hertfordshire are screening up to 400 students from various ethnic groups to gauge their predisposition to heart disease in later life. Professor Nigel Baber (Clinical Trials Co-ordinating Centre) and Dr Andrew Garrett (School of Life Sciences) have joined forces with researchers from the Universities of Cambridge and Cardiff in the British Heart Foundation-funded Enigma-E research project into heart and blood vessel health. Read more »
|
Calcium Scans May Be Effective Screening Tool For Heart Disease
30.09.2009 22:00 16 views 0 comments
 A simple, non-invasive test appears to be an effective screening tool for identifying patients with silent heart disease who are at risk for a heart attack or sudden death. Coronary artery calcium scans can be done without triggering excessive additional testing and costs, according to the multi-center EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) study, led by investigators at the Cedars-Sinai Heart Institute. Read more »
|
Larry King To Moderate Panel Of Leading Cardiologists And Cardiac Surgeons
30.09.2009 21:00 17 views 0 comments
 What The Ninth Annual Controversies and Advances in Treatment of Cardiovascular Disease continuing medical education conference will feature several discussions and presentations on how healthcare reform could affect cardiovascular disease patients' diagnosis, treatment and outcome. Read more »
|
Despite Size, NFL Players Not More Likely To Develop Heart Disease, Even After Retirement
30.09.2009 20:00 17 views 0 comments
 Former professional football players with large bodies don't appear to have the same risk factors for heart disease as their non-athletic counterparts, UT Southwestern Medical Center researchers have found in studying a group of National Football League (NFL) alumni. Compared to other men in a similar age range, retired NFL players had a significantly lower prevalence of diabetes, hypertension, sedentary lifestyles and metabolic syndrome, the study authors report. Read more »
|
St. Jude Medical Announces Australian Launch Of Devices That Diagnose And Treat Abnormal Heart Rhythms
30.09.2009 8:00 17 views 0 comments
 St. Jude Medical, Inc. (NYSE:STJ) today announced it has launched several new cardiac rhythm management devices for the treatment and diagnosis of abnormal heart rhythms. Read more »
|
Soybeans Contain Compounds That Could Prevent Heart Disease And Cancer
30.09.2009 8:00 20 views 0 comments
 Soybeans contain high levels of several health-beneficial compounds including tocopherols, which have antioxidant properties. These molecules can be used in the development of functional foods, which have specific health-beneficial properties and can be used in the treatment or prevention of diseases. Tocopherols exist in four forms (α, β, γ, and δ) of which γ-tocopherol is found in greatest concentration in soybeans. Read more »
|
CardiAQ Valve Technologies (CVT) Discloses Successful Results Of Acute In Vivo Study Of Its Novel Transcatheter Mitral Valve Implantation (TMVI) Syste
30.09.2009 3:00 17 views 0 comments
 Transcatheter heart valve company CardiAQ Valve Technologies (CVT), which is developing the world's first self-conforming and self-anchoring technology for Transcatheter Mitral Valve Implantation (TMVI), announced today that successful results of an acute in vivo study of its TMVI system were disclosed by Dr. Read more »
|
Excelsior Medical Launches SwabCap To Disinfect Catheter Luer Access Valves
30.09.2009 3:00 35 views 0 comments
Excelsior Medical, one of the leading manufacturers of pre-filled catheter flush syringes and syringe pump systems, announced that it has launched a major new product: the SwabCap ™ Luer Access Valve Disinfection Cap. SwabCap™ is a simple twist-on device that disinfects swab-able luer access valves prior to catheter line access. Read more »
|
Genotyping In Samoa Being Funded By $5.2 Million From NIH
30.09.2009 3:00 22 views 0 comments
 Do some people have special "susceptibility" genes that make them vulnerable to obesity and diabetes, triggered by poor diet and less exercise? Stephen McGarvey, professor of community health and anthropology at Brown University, will attempt to answer that question as part of a new a five-year, $5.2-million National Institutes of Health grant to conduct detailed genotyping of thousands of adults in the independent nation of Samoa. Read more »
|
